117 related articles for article (PubMed ID: 3321918)
1. [Open clinical trial with haloperidol decanoate in patients with psychotic disorders].
Ellerman LA
Acta Psiquiatr Psicol Am Lat; 1987 Jun; 33(2):157-62. PubMed ID: 3321918
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the efficacy of haloperidol decanoate].
Alvarez JV; Li Gambi M
Acta Psiquiatr Psicol Am Lat; 1986 Sep; 32(3):233-6. PubMed ID: 2884807
[TBL] [Abstract][Full Text] [Related]
3. [Haloperidol decanoate: results of a 6-month open trial in paranoid schizophrenia].
Pérez C; Stier Rosner SE
Acta Psiquiatr Psicol Am Lat; 1989; 35(3-4):111-5. PubMed ID: 2576990
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of effectiveness and tolerance of the long-term treatment with bromoperidol decanoate in psychotic disorders].
Levi Minzi A; Laviani M
Minerva Psichiatr; 1992; 33(1):51-5. PubMed ID: 1406161
[TBL] [Abstract][Full Text] [Related]
5. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
Roose K
Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the efficacy of haloperidol decanoate in the treatment of chronic psychotic hospital patients].
Marchant N; Caruso S; Cuervo L; Brizuela A
Acta Psiquiatr Psicol Am Lat; 1985 Mar; 31(1):37-41. PubMed ID: 2864788
[TBL] [Abstract][Full Text] [Related]
7. [Haloperidol decanoate. Results of an open-ended multicentric study in chronic psychotic states].
Lemperiere T; Ropert R; Leger JM; Alexandre JY; Clerc G; Darondel A; Delaunay J; Delteil P; Malauzat D; Raynaud J
Encephale; 1984; 10(5):217-22. PubMed ID: 6519017
[TBL] [Abstract][Full Text] [Related]
8. [Clinical experience with bromperidol in chronic psychoses].
Bellomo LE; Rosset N; Tellarini L; Forconesi N
Acta Psiquiatr Psicol Am Lat; 1988 Sep; 34(3):230-6. PubMed ID: 3071092
[TBL] [Abstract][Full Text] [Related]
9. Relative efficacy of parenteral haloperidol and thiothixene for the emergency treatment of acutely excited and agitated patients.
Stotsky BA
Dis Nerv Syst; 1977 Dec; 38(12):967-73. PubMed ID: 338270
[TBL] [Abstract][Full Text] [Related]
10. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
[TBL] [Abstract][Full Text] [Related]
11. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
12. Preliminary note on the antipsychotic efficacy of bromperidol.
Bataille M
Acta Psychiatr Belg; 1978; 78(1):173-9. PubMed ID: 347879
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of clinical usefulness of decaldol (haloperidol decanoate) produced by WZF Polfa in Warsaw in long-term treatment of schizophrenia].
Morasiewicz J; Baranowski P; Borys J; Jańska-Skomorowska M; Kiejna A
Psychiatr Pol; 1995; 29(3):405-20. PubMed ID: 7652093
[TBL] [Abstract][Full Text] [Related]
14. [Use of very high doses of haloperidol in the treatment of acute psychotic episodes. Clinical and pharmacokinetic analysis apropos of 15 cases].
Petit P; Blayac JP; Castelnau D; Billet J; Puech R; Pouget R
Encephale; 1987; 13(3):127-30. PubMed ID: 3595515
[TBL] [Abstract][Full Text] [Related]
15. Kinetics and clinical evaluation of haloperidol decanoate loading dose regimen.
Ereshefsky L; Saklad SR; Tran-Johnson T; Toney G; Lyman RC; Davis CM
Psychopharmacol Bull; 1990; 26(1):108-14. PubMed ID: 2371365
[TBL] [Abstract][Full Text] [Related]
16. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
Wistedt B
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
[TBL] [Abstract][Full Text] [Related]
17. Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.
Neborsky RJ; Janowsky DS; Perel JM; Munson E; Depry D
J Clin Psychiatry; 1984 Jan; 45(1):10-3. PubMed ID: 6363395
[TBL] [Abstract][Full Text] [Related]
18. A clinical trial comparing intramuscular haloperidol decanoate and oral haloperidol in chronic schizophrenic patients: efficacy, safety, and dosage equivalence.
Vasavan Nair NP; Suranyi-Cadotte B; Schwartz G; Thavundayil JX; Achim A; Lizondo E; Nayak R
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):30S-37S. PubMed ID: 3514689
[TBL] [Abstract][Full Text] [Related]
19. A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
Wei FC; Jann MW; Lin HN; Piao-Chien C; Chang WH
J Clin Psychiatry; 1996 Jul; 57(7):298-302. PubMed ID: 8666571
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration.
De Cuyper H; Bollen J; van Praag HM; Verstraeten D
Br J Psychiatry; 1986 May; 148():560-6. PubMed ID: 2877701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
